Gynecology 2025

Dear Attendees, it is my pleasure to write a few welcome notes for the 3rd Edition of Global Conference on Gynecology & Women‘s Health (HYBRID Event), Orlando, FL, U.S.A. Pelvic Organ Prolapse (POP) and female urinary dysfunction can cause women discomfort and impact their quality of life. POP and urinary dysfunction precipitate disparities facing women globally. The resulting shame and isolation reflect health inequities and sociocultural disparities. The reported prevalence of POP varies widely, ranging from 3 to 50% Therefore, up-to-date and comprehensive evidence in managing POP and other pelvic floor disorders is essential to offer standardized care for women. I hope this conference provides a variety of opportunities to expand your knowledge and interest in women’s health.

Esteemed Colleagues

It is a true honour to welcome you to this International Congress on Gynaecology and Women's Health. We are deeply pleased to host such a distinguished gathering of clinicians, researchers, and healthcare professionals worldwide, united by a shared commitment to advancing the science and care of women's health..

This congress represents a unique opportunity to exchange knowledge, share experiences, and foster international collaboration. Together, we will explore the most significant challenges in uro-gynaecology and gynaecology, address the complexities of infertility and its treatments, discuss high-risk pregnancy and its management, and deepen our understanding of the molecular mechanisms underlying various pathologies. We will also consider the promising role of artificial intelligence and its future applications in our field.

Beyond the scientific programme, we can build lasting connections-collaborations that will enrich our individual work and contribute to a stronger, more unified global medical community.

I wish you all a most successful and inspiring congress.

Dear congress visitors

Dear congress visitors, it is honor and pleasure to write a few welcome notes for this important conference.

Pregnancy is a period that a healthy woman is going to give life to her developing fetus.  This gestational period the haemostatic system progressively changes to prepare the haemostatic needs of delivery and postpartum. Many coagulation factors normally change and microthrombi are formed and lysed continuously within the venous circulatory system.

Pulmonary embolism is a complication of venous thrombosis and is leading cause of pregnancy related deaths at any trimester if the proper diagnosis and therapy is delayed. The causes of pulmonary embolism are multifactorial.  It is most common cause of maternal death in pregnancy, but extremely common disorder without specific clinical features.

The correct differential diagnose is crucial and early anticoagulation is the first therapeutic measure when a high level of suspicion exist. Despite of improved physician’s ability to diagnose and treat pulmonary embolism in pregnancy, several areas need further research.

Dear Conference attendees - Gynec 2025

It is with great honor and enthusiasm that I welcome you all to Gynec 2025. This conference serves as a crucial platform to explore groundbreaking advancements and address key challenges shaping the future of women’s health. Recent years have witnessed remarkable progress in gynecological care, from cutting-edge diagnostics and minimally invasive procedures to transformative breakthroughs in reproductive medicine. Innovations such as next-generation sequencing, biomarker-based screening, and artificial intelligence-driven diagnostics can revolutionize the management of various gynecological conditions. As the burden of gynecologic diseases continues to evolve, addressing healthcare disparities and ensuring equitable access to innovative treatments remain paramount. Gynec 2025 aims to bridge the gap between scientific discovery and clinical application, fostering interdisciplinary collaborations that drive the next generation of gynecological care. Through collaboration and knowledge-sharing, we can shape a future where women’s healthcare is not only preventive but also predictive and personalized.

Wishing you all a highly productive and intellectually stimulating Gynec 2025!

Dear Esteemed Global Conference Attendees

Dear esteemed Global Conference delegates , It indeed is an honour to be amongst you all as a Scientific Committee and Keynote speaker. I sincerely thank the organisers for giving me this wonderful opportunity to showcase my ongoing study on “Efficacy of Full PIERS calculator in predicting adverse maternal outcomes in Pre-eclampsia in a tertiary care centre in South India” It is well known that Pre-eclampsia is a leading cause of maternal mortality and morbidity all over the globe. It also contributes significantly to neonatal mortality and morbidity. Management of Pre-eclampsia may include increased maternal and fetal surveillance with a tight blood pressure control and seizure prophylaxis, but ultimately delivery of the fetus is the only definitive treatment. Hence it is important to identify the women who are at risk for adverse outcomes ,so that they can be attended with more surveillance at a higher well-equipped centre in order to get a favourable maternal and neonatal outcome. The Full PIERS calculator may be the magic tool to identify such cases. This has encouraged me to take up this study and be amongst you all to share my inputs.